Publications by authors named "Miguel Goicoechea"

24Publications

No Impact of Probiotics to Reduce Infection in Hospitalized Patients: A Real-world Experience.

Open Forum Infect Dis 2018 Dec 13;5(12):ofy192. Epub 2018 Dec 13.

Division of Infectious Diseases, Scripps Health, San Diego, California.

View Article and Find Full Text PDF
December 2018

Nucleoside-Sparing Regimens With Raltegravir and a Boosted Protease Inhibitor: An Unsettled Issue.

J Acquir Immune Defic Syndr 2016 06;72(2):e48-50

*Department of Medicine, University of California, San Diego, CA †Department of Family Medicine and Public Health, University of California, San Diego, CA ‡Kaiser Permanente, San Diego, CA §Scripps Health San Diego, San Diego, CA ‖Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA ¶Desert Regional Medical Center, Palm Springs, CA #Santa Clara Valley Medical Center, San Jose, CA **University California Irvine, Irvine, CA ††Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center and the David Geffen School of Medicine at UCLA, Los Angeles, CA ‡‡Gilead Sciences, Foster City, CA.

View Article and Find Full Text PDF
June 2016

Maraviroc intensification in patients with suppressed HIV viremia has limited effects on CD4+ T cell recovery and gene expression.

Antiviral Res 2014 Jul 24;107:42-9. Epub 2014 Apr 24.

Department of Medicine and Division of Infectious Diseases, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA. Electronic address:

View Article and Find Full Text PDF
July 2014

Didanosine Exposure and Noncirrhotic Portal Hypertension in a HIV Clinic in North America: a Follow-up Study.

Br J Med Med Res 2011 ;1(4):346-355

Department of Medicine, University of California at San Diego, San Diego, California, United States.

View Article and Find Full Text PDF
January 2011

Abacavir and increased risk of myocardial infarction.

Lancet 2008 Sep;372(9641):803-4; author reply 804-5

View Article and Find Full Text PDF
September 2008

Efavirenz--still first-line king?

Expert Opin Drug Metab Toxicol 2008 Jul;4(7):965-72

University of California, Division of Pharmacology and Drug Discovery, San Diego, La Jolla, CA 92093-0719, USA.

View Article and Find Full Text PDF
July 2008

Human H5N1 influenza.

N Engl J Med 2007 Mar;356(13):1375; author reply 1376-7

View Article and Find Full Text PDF
March 2007

Efavirenz/emtricitabine/tenofovir disoproxil fumarate fixed-dose combination: first-line therapy for all?

Expert Opin Pharmacother 2007 Feb;8(3):371-82

University California, School of Medicine, San Diego, CA 92103, USA.

View Article and Find Full Text PDF
February 2007